COMMUNIQUÉS West-GlobeNewswire

Aptose to Present at the Jefferies 2019 Healthcare Conference
31/05/2019
SAN DIEGO and TORONTO, May 31, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes [...]
ContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split
31/05/2019
Reverse stock split intended to bring company into compliance with minimum bid price requirement for maintaining listing on Nasdaq Capital Market EDISON, N.J., May 31, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals [...]
YSS Corp.™ (formerly Solo Growth Corp.) Announces 2019 Construction Update, Name Change to YSS Corp and New Corporate Presentation
31/05/2019
CALGARY, Alberta, May 31, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (TSXV: SOLO) (WKN:A2PBMC) (formerly Solo Growth Corp.), a cannabis retailer operating as YSS TM with the vision to become a premier retailer and the trusted [...]
BioCryst to Present at Upcoming Investor Conferences
31/05/2019
RESEARCH TRIANGLE PARK, N.C., May 31, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the Jefferies 2019 Healthcare Conference in New York on [...]
Updated Results of Studies in Advanced Cervical Cancer and Melanoma Support Long-Term Efficacy of Iovance Tumor Infiltrating Lymphocyte (TIL) Therapy
31/05/2019
Complete Response rate of 11 percent observed in the LN-145 study in cervical cancer Median duration of response has not been reached at 7.4 month median follow-up in the ongoing study of LN-145 in advanced cervical [...]
Cara Therapeutics to Present at the Jefferies 2019 Healthcare Conference
31/05/2019
STAMFORD, Conn., May 31, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus by [...]
Axovant to Present at Upcoming Conferences in June
31/05/2019
BASEL, Switzerland, May 31, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (Nasdaq: AXGT), a clinical-stage company developing innovative gene therapies, today announced that Pavan Cheruvu, M.D., chief executive [...]
ContraFect Announces Publication of Paper on Recent Exebacase Data in Antimicrobial Agents and Chemotherapy Journal
31/05/2019
Exebacase concentrations below the minimum inhibitory concentration (sub-MIC) demonstrated sustained reductions in bacterial fitness and virulence of Staphylococcus aureus YONKERS, N.Y., May 31, 2019 (GLOBE NEWSWIRE [...]
Iovance Biotherapeutics to Participate in Upcoming Conferences in June
31/05/2019
SAN CARLOS, Calif., May 31, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]
Herantis Pharma Oyj: Manager’s Transactions - Pekka Mattila
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - Pekka Mattila Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager’s Transactions - Timo Veromaa
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - Timo Veromaa Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager’s Transactions - Frans Wuite
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - Frans Wuite Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
31/05/2019
RANCHO CUCAMONGA, Calif., May 31, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President and Bill Peters, CFO, will be presenting at the Jefferies 2019 [...]
Herantis Pharma Oyj: Manager’s Transactions - Pekka Simula
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - Pekka Simula Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager’s Transactions - James Phillips
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - James Phillips Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager’s Transactions - Inveni Life Sciences Fund I Ky
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - Inveni Life Sciences Fund I Ky Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions [...]
ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for ASLAN004 From CSL
31/05/2019
- Amending their previous agreement, CSL grants ASLAN full global rights to develop, manufacture and commercialise ASLAN004 SINGAPORE, May 31, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a [...]
Oncology Venture publishes Q1 report for 2019
31/05/2019
Company Announcement Hoersholm, Denmark – May 31, 2019 – Oncology Venture A/S (OV:ST) (“Oncology Venture”) today publishes the Interim Report for the first quarter of 2019. The Interim Report is available as an attached [...]
Kiadis Pharma raises c.EUR 28 million in a private placement of c.3.7 million new shares
31/05/2019
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release, publication or distribution [...]

Pages